Showing 1 - 20 results of 26 for search 'Kill off', query time: 0.06s Refine Results
  1. 1

    What was Killing Babies in Ipswich Between 1872 and 1909? by Eilidh Garrett, Alice Reid

    Published 2022-07-01
    “…While water-food borne diseases killed large numbers in the summer months, it was the ever-present airborne diseases which carried off a greater number of small victims. …”
    Get full text
    Article
  2. 2
  3. 3

    Does a biological invasion modify host immune responses to parasite infection? by Gregory P. Brown, Richard Shine, Lee A. Rollins

    Published 2025-01-01
    “…Infected toads also exhibited lower bacteria-killing ability, perhaps reflecting a trade-off of resources towards defences that are more specifically anthelminthic. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6

    Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells by Zamaneh Hajikhezri, Ioannis Zygouras, Anders Sönnerborg, Robert van Domselaar

    Published 2025-02-01
    “…Abstract The persistence of HIV-1 latency reservoirs in CD4+ T cells is a significant obstacle for curing HIV-1. Shock-and-kill strategies, which aim to reactivate latent HIV-1 followed by cytotoxic clearance, have shown limited success in vivo due to insufficient efficacy of latency reversal agents (LRAs) and off-target effects. …”
    Get full text
    Article
  7. 7
  8. 8

    Toxicity Assessment of the Xanthid Crab Demania cultripes from Cebu Island, Philippines by Manabu Asakawa, Gloria Gomez-Delan, Shintaro Tsuruda, Michitaka Shimomura, Yasuo Shida, Shigeto Taniyama, Mercy Barte-Quilantang, Jo Shindo

    Published 2010-01-01
    “…The activity was expressed in mouse unit (MU) being defined as the amount of TTX to kill a 20 g ddY male mice in 30 min after i.p. injection. …”
    Get full text
    Article
  9. 9
  10. 10

    Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen by Yu-Chan Chih, Amelie C. Dietsch, Philipp Koopmann, Xiujian Ma, Dennis A. Agardy, Binghao Zhao, Alice De Roia, Alexandros Kourtesakis, Michael Kilian, Christopher Krämer, Abigail K. Suwala, Miriam Stenzinger, Halvard Boenig, Agnieszka Blum, Victor Murcia Pienkowski, Kuralay Aman, Jonas P. Becker, Henrike Feldmann, Theresa Bunse, Richard Harbottle, Angelika B. Riemer, Hai-Kun Liu, Nima Etminan, Felix Sahm, Miriam Ratliff, Wolfgang Wick, Michael Platten, Edward W. Green, Lukas Bunse

    Published 2025-02-01
    “…The validated vaccine-induced TCR recognizes the endogenously processed antigen without off-target cross-reactivity. PTPRZ1-specific TCR-T (PTPRZ1-TCR-T) kill target cells antigen-specifically, and in murine experimental brain tumors, their combined intravenous and intracerebroventricular administration is efficacious. …”
    Get full text
    Article
  11. 11
  12. 12
  13. 13

    Editorial by Jörg Tremmel, Markus Rutsche

    Published 2022-04-01
    “…This policy paper starts off with a historical overview on how pandemics have afflicted humanity in the past. …”
    Get full text
    Article
  14. 14

    Iconic Celebration of Charms and Friendship in Poetry: Fálétí’s “Adébímpé Ọ̀jẹ́dòkun” by Michael Oladejo Afoláyan

    Published 2021-12-01
    “…The second hunter finished off the animal with the shot right on target with a sniper’s propensity. …”
    Get full text
    Article
  15. 15

    Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies by Yan-Ruide Li, Ying Fang, Siyue Niu, Yichen Zhu, Yuning Chen, Zibai Lyu, Enbo Zhu, Yanxin Tian, Jie Huang, Valerie Rezek, Scott Kitchen, Tzung Hsiai, Jin J. Zhou, Pin Wang, Wanxing Chai-Ho, Sunmin Park, Christopher S. Seet, Caspian Oliai, Lili Yang

    Published 2025-02-01
    “…Furthermore, CAR-NKT cells synergize with hypomethylating agents, enhancing tumor-killing efficacy. These cells also show minimal off-tumor toxicity, reduced graft-versus-host disease and cytokine release syndrome risks, and resistance to allorejection, highlighting their substantial therapeutic potential for treating myeloid malignancies.…”
    Get full text
    Article
  16. 16

    PREVENTING VIOLENCE CRIMES (KIDNAPPING, ARMED ROBBERY, BRIGANDAGE OR COMMUNITY MASSACRE) WITH DRONES: AN EFFECTIVE ALTERNATIVE TO VEHICULAR PATROLS IN NIGERIA by GABRIEL SALIFU, DANIEL OLASUNKANMI OLADAPO

    Published 2024-07-01
    “…In the 21st century, the families off springs are endangered with multiple social vices that range from internet fraud (yahoo yahoo), kidnapping, lesbianism, drug abuse, homosexuality, bestiality, incest, ritual killing and others. …”
    Get full text
    Article
  17. 17

    The Molecular Imaging of Natural Killer Cells by Mariya Shapovalova, Sean R. Pyper MD, PhD, Branden S. Moriarity PhD, Aaron M. LeBeau PhD

    Published 2018-09-01
    “…Natural killer cells are cytotoxic lymphocytes that mediate the direct killing of transformed cells with reduced or absent major histocompatibility complex (MHC) and are the effector cells in antibody-dependent cell-mediated cytotoxicity. …”
    Get full text
    Article
  18. 18

    Transition Yet Energy Consuming for Tumor Growth Regulated by the Colored Microenvironment by Leiyan Chen, Yan Wang, Qingqing Li, Haohua Wang

    Published 2023-01-01
    “…Moreover, by reconstructing the reaction network from the mesoscopic scale, we further show that AT of multiplicative noise can increase energy consumption, and there exists a trade-off between NS and AT of additive noise. We also show that the energy consumption is monotonically decreasing with increasing the CT but the CS can amplify the difference of this dependence. …”
    Get full text
    Article
  19. 19

    Study of an arginine- and tryptophan-rich antimicrobial peptide in peri-implantitis by Qian Zhang, Yalei Jiang, Xiaotong He, Liwei Liu, Xi Zhang

    Published 2025-01-01
    “…Therefore, VR-12 may be a good option for both warding off and treatmenting peri-implantitis.…”
    Get full text
    Article
  20. 20

    Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy by Amelia C. McCue, Stephen J. Demarest, Karen J. Froning, Michael J. Hickey, Stephen Antonysamy, Brian Kuhlman

    Published 2024-12-01
    “…We demonstrate with binding experiments and in vitro T-cell activation and killing assays that our designed prodrug TCE is capable of tumor-selective T-cell activity that is dependent upon MMP-2. …”
    Get full text
    Article